PIAS 1 Antibodies

Santa Cruz Biotechnology features a diverse variety of PIAS 1 monoclonal antibodies for investigating the role of PIAS 1 protein. PIAS 1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PIAS 1, or Protein Inhibitor of Activated STAT 1, functions as a key regulator of the JAK-STAT signaling pathway, which plays a vital role in mediating cellular responses to cytokines and growth factors. Through modulation of STAT proteins, PIAS 1 influences various biological processes, including immune response, cell proliferation, and apoptosis. Research focused on PIAS 1 continues to reveal significant insights into cancer development and autoimmune disorders. PIAS 1 monoclonal antibodies enable precise detection and characterization of PIAS 1 expression patterns across different cellular compartments. Researchers can utilize PIAS 1 monoclonal antibodies to examine protein-protein interactions and signaling cascades in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies for PIAS 1 support researchers worldwide in advancing our understanding of cellular signaling mechanisms and disease pathways.